hotspot -WSS

hotspot

author：focus 2025-10-02 04:07:56 - browse：7

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： A daunting task: navigating dual Medicare, Medicaid eligibility

explore

WSS

Childhood cancer progress stalls for Black, Hispanic kids: Report

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Immune cells and nerve overgrowth may explain recurring UTI pain

Harvard's David Sinclair gets blowback over aging

Fetal cell organoids grown from amniotic fluid, study finds

Does good food count as health care? Study aims to find out

Wikipedia

hotspot

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Harvard's David Sinclair gets blowback over aging

Medicare details structure of new drug price negotiation program

Ancient Greek ideas underpin modern concepts of pregnancy

What does generative AI mean for health care? We asked experts

David Sabatini, ex

Activists slam private health insurers over coverage restrictions

A new approach to psychiatric drug development

Anesthesiologist group: stop taking Ozempic before surgery

Microsoft's Peter Lee: Generative AI could help doctors be more human

focus

For AI in health care standards, federal regulators join with industry group

Astellas still sees hope in its gene therapy after four deaths

Medicare drug price negotiation continues, as pharma counteroffers

$1 billion proposal to grow Boston, Massachusetts biotech

A new approach to psychiatric drug development

The public health thinking behind the CDC’s new Covid guidance

hotspot

explore

explore

hotspot